A DAXX-KIFC3 fusion potentiates alternative lengthening of telomeres in osteosarcoma

被引：0
|
作者：
Soper, Sarah F. Clatterbuck
Showman, Soyeon A.
Driest, Kathryn E.
Waterfall, Joshua J.
Walker, Robert L.
Pineda, Marbin A.
Zhu, Yuelin J.
Wang, Yonghong
Ester, Corbin D.
Bilke, Sven
Meltzer, Paul S.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-3467
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3467
引用
收藏
页数：2
相关论文
共 38 条
  • [21] Loss of ATRX/DAXX Immunohistochemical Expression as a Surrogate for Alternative Lengthening of Telomeres (ALT)-Positivity is Associated with Adverse Clinicopathologic Features in Pancreatic Neuroendocrine Tumors
    Choi, Allen
    Abukhiran, Ibrahim
    Bellizzi, Andrew
    LABORATORY INVESTIGATION, 2023, 103 (03) : S485 - S487
  • [22] The FANCM-BLM-TOP3A-RMI complex suppresses alternative lengthening of telomeres (ALT)
    Lu, Robert
    O'Rourke, Julienne J.
    Sobinoff, Alexander P.
    Allen, Joshua A. M.
    Nelson, Christopher B.
    Tomlinson, Christopher G.
    Lee, Michael
    Reddel, Roger R.
    Deans, Andrew J.
    Pickett, Hilda A.
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [23] The FANCM-BLM-TOP3A-RMI complex suppresses alternative lengthening of telomeres (ALT)
    Robert Lu
    Julienne J. O’Rourke
    Alexander P. Sobinoff
    Joshua A. M. Allen
    Christopher B. Nelson
    Christopher G. Tomlinson
    Michael Lee
    Roger R. Reddel
    Andrew J. Deans
    Hilda A. Pickett
    Nature Communications, 10
  • [24] Endoscopic ultrasound fine-needle biopsy to assess DAXX/ATRX expression and alternative lengthening of telomeres status in non-functional pancreatic neuroendocrine tumors
    Mastrosimini, Maria Gaia
    Manfrin, Erminia
    Remo, Andrea
    De Bellis, Mario
    Parisi, Alice
    Pedron, Serena
    Luchini, Claudio
    Brunelli, Matteo
    Ammendola, Serena
    Bernardoni, Laura
    Bellocchi, Maria Cristina Conti
    Gabbrielli, Armando
    Facciorusso, Antonio
    Pea, Antonio
    Landoni, Luca
    Scarpa, Aldo
    Crino, Stefano Francesco
    PANCREATOLOGY, 2023, 23 (04) : 429 - 436
  • [25] Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors
    de Wilde, Roeland F.
    Heaphy, Christopher M.
    Maitra, Anirban
    Meeker, Alan K.
    Edil, Barish H.
    Wolfgang, Christopher L.
    Ellison, Trevor A.
    Schulick, Richard D.
    Molenaar, I. Quintus
    Valk, Gerlof D.
    Vriens, Menno R.
    Rinkes, Inne H. M. Borel
    Offerhaus, G. Johan A.
    Hruban, Ralph H.
    Matsukuma, Karen E.
    MODERN PATHOLOGY, 2012, 25 (07) : 1033 - 1039
  • [26] Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size
    Hackeng, Wenzel M.
    Brosens, Lodewijk A. A.
    Kim, Joo Young
    O'Sullivan, Roderick
    Sung, You-Na
    Liu, Ta-Chiang
    Cao, Dengfeng
    Heayn, Michelle
    Brosnan-Cashman, Jacqueline
    An, Soyeon
    Morsink, Folkert H. M.
    Heidsma, Charlotte M.
    Valk, Gerlof D.
    Vriens, Menno R.
    van Dijkum, Els Nieveen
    Offerhaus, G. Johan A.
    Dreijerink, Koen M. A.
    Zeh, Herbert
    Zureikat, Amer H.
    Hogg, Melissa
    Lee, Kenneth
    Geller, David
    Marsh, J. Wallis
    Paniccia, Alessandro
    Ongchin, Melanie
    Pingpank, James F.
    Bahary, Nathan
    Aijazi, Muaz
    Brand, Randall
    Chennat, Jennifer
    Das, Rohit
    Fasanella, Kenneth E.
    Khalid, Asif
    McGrath, Kevin
    Sarkaria, Savreet
    Singh, Harkirat
    Slivka, Adam
    Nalesnik, Michael
    Han, Xiaoli
    Nikiforova, Marina N.
    Lawlor, Rita Teresa
    Mafficini, Andrea
    Rusev, Boris
    Corbo, Vincenzo
    Luchini, Claudio
    Bersani, Samantha
    Pea, Antonio
    Cingarlini, Sara
    Landoni, Luca
    Salvia, Roberto
    GUT, 2022, 71 (05) : 961 - 973
  • [27] Author Correction: The FANCM-BLM-TOP3A-RMI complex suppresses alternative lengthening of telomeres (ALT)
    Robert Lu
    Julienne J. O’Rourke
    Alexander P. Sobinoff
    Joshua A. M. Allen
    Christopher B. Nelson
    Christopher G. Tomlinson
    Michael Lee
    Roger R. Reddel
    Andrew J. Deans
    Hilda A. Pickett
    Nature Communications, 10
  • [28] Glucagon-Producing Pancreatic Neuroendocrine Tumors (Glucagonomas) are Enriched in Aggressive Neoplasms with ARX and PDX1 Co-expression, DAXX/ATRX Mutations, and ALT (Alternative Lengthening of Telomeres)
    Mattiolo, Paola
    Bevere, Michele
    Mafficini, Andrea
    Verschuur, Anna Vera D.
    Calicchia, Martina
    Hackeng, Wenzel M.
    Simbolo, Michele
    Paiella, Salvatore
    Dreijerink, Koen M. A.
    Landoni, Luca
    Pedron, Serena
    Cingarlini, Sara
    Salvia, Roberto
    Milella, Michele
    Lawlor, Rita T.
    Valk, Gerlof D.
    Vriens, Menno R.
    Scarpa, Aldo
    Brosens, Lodewijk A.
    Luchini, Claudio
    ENDOCRINE PATHOLOGY, 2024, 35 (04) : 354 - 361
  • [29] The FANCM-BLM-TOP3A-RMI complex suppresses alternative lengthening of telomeres (ALT) (vol 10, 2252, 2019)
    Lu, Robert
    O'Rourke, Julienne J.
    Sobinoff, Alexander P.
    Allen, Joshua A. M.
    Nelson, Christopher B.
    Tomlinson, Christopher G.
    Lee, Michael
    Reddel, Roger R.
    Deans, Andrew J.
    Pickett, Hilda A.
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [30] Alternative Lengthening of Telomeres and Loss of DAXX/ATRX Expression in Pancreatic Neuroendocrine Tumors from Endoscopic Ultrasound Guided Fine Needle Aspiration (EUS-FNA) Specimens Correlate with Poor Patient Survival
    Theisen, Brian
    Roncaioli, Justin L.
    O'Sullivan, Roderick J.
    McGrath, Kevin
    Brand, Randall E.
    Zeh, Herbert J.
    Chennat, Jennifer S.
    Fasanella, Kenneth E.
    Khalid, Asif
    Papachristou, Georgios I.
    Slivka, Adam
    Nilaforova, Marina N.
    Hogg, Melissa
    Singhi, Aatur D.
    MODERN PATHOLOGY, 2017, 30 : 120A - 120A
1234